Xulane FDA Approval History
FDA Approved: Yes (First approved April 16, 2014)
Brand name: Xulane
Generic name: ethinyl estradiol and norelgestromin
Dosage form: Transdermal System
Company: Mylan Pharmaceuticals Inc.
Treatment for: Birth Control
Xulane (ethinyl estradiol and norelgestromin transermal system) is a generic version of Ortho Evra, a birth control patch used to prevent pregnancy.
Development timeline for Xulane
| Date | Article |
|---|---|
| Apr 18, 2014 | Approval Mylan Launches Xulane - First Generic Ortho Evra Patch |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.